Publikationen (53) Publikationen von ENRIQUE ALAVA CASADO

2019

  1. Preclinical efficacy of endoglin-targeting antibody–drug conjugates for the treatment of Ewing sarcoma

    Clinical Cancer Research, Vol. 25, Núm. 7, pp. 2228-2240

2017

  1. GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)

    British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774

2016

  1. Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid

    Human Pathology, Vol. 48, pp. 132-141

  2. Molecular pathology of bone and soft tissue tumors

    The Molecular Basis of Human Cancer (Springer New York), pp. 623-655

  3. Proteomic Profiling of Ewing Sarcoma Reveals a Role for TRAF6 in Proliferation and Ribonucleoproteins/RNA Processing

    Journal of Proteomics & Bioinformatics, Vol. 09, Núm. 06

  4. Sarcoma histiocítico en intestino delgado: estudio y discusión de un caso con reordenamiento clonal linfoide B

    Revista Espanola de Patologia, Vol. 49, Núm. 4, pp. 254-258

2015

  1. The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget, Vol. 6, Núm. 22, pp. 18875-18890

  2. Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents

    Clinical Cancer Research, Vol. 21, Núm. 6, pp. 1373-1382

2014

  1. Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications

    PLoS ONE, Vol. 9, Núm. 2

  2. Contribution of the R-Ras2 GTP-binding protein to primary breast tumorigenesis and late-stage metastatic disease

    Nature Communications, Vol. 5

  3. Innovative therapies in ewing sarcoma

    Advances in Anatomic Pathology, Vol. 21, Núm. 1, pp. 44-62

  4. Tumor desmoplásico de células pequeñas y redondas en pared torácica

    Revista Espanola de Patologia, Vol. 47, Núm. 1, pp. 41-44

2013

  1. EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1

    PLoS ONE, Vol. 8, Núm. 8

  2. Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma

    Journal of Biological Regulators and Homeostatic Agents, Vol. 27, Núm. 2, pp. 559-567

  3. Round Cell Tumors

    Practical Soft Tissue Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series (Elsevier), pp. 221-234

  4. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis

    Carcinogenesis, Vol. 34, Núm. 2, pp. 268-276

  5. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells

    Oncogene, Vol. 32, Núm. 11, pp. 1441-1451

2012

  1. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

    Oncogene, Vol. 31, Núm. 10, pp. 1287-1298

  2. A new multidisciplinary Spanish Working Group on Cancer Biomarkers: Presentation and aims

    Clinical and Translational Oncology

  3. Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome

    Pediatric Blood and Cancer, Vol. 58, Núm. 4, pp. 532-538